[1]
“The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren’s syndrome”, Clinics, vol. 74, p. e631, Jun. 2019, doi: 10.6061/clinics/2019/e631.